High PLOD1 expression predicts poor overall and DFS in multiple cancers, including breast cancer [100,101,102]), and PLOD1 inhibition (via siRNA or small molecules) attenuates proliferation, migration, and invasion in bladder cancer and glioma models [97,103]. Here, PLOD1 is linked to urinary bladder cancer.